Heteroaryl urea derivatives useful for inhibiting CHK1
US8093244B2 · kind B2 · utility
8Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2006 |
| Grant date | Jan 10, 2012 |
| Priority date | — |
| Expiry date | Jan 16, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substituted urea compounds useful in the treatment of diseases and conditions related to DNA damage or lesions in DNA replication are disclosed. Methods of making the compounds, and their use as therapeutic agents, for example, in treating cancer and other diseases characterized by defects in DNA replication, chromosome segregation, or cell division, also are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.